US Stock MarketDetailed Quotes

IKNA Ikena Oncology

Watchlist
  • 1.670
  • -0.050-2.91%
Close Sep 17 16:00 ET
  • 1.670
  • 0.0000.00%
Post 16:00 ET
80.59MMarket Cap-1176P/E (TTM)

Ikena Oncology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
0
0
-41.35%9.16M
-87.91%659K
-81.49%1.19M
424.61%2M
57.00%5.31M
-49.59%15.62M
-73.04%5.45M
70.90%6.4M
Operating revenue
--0
--0
-41.35%9.16M
-87.91%659K
-81.49%1.19M
424.61%2M
57.00%5.31M
-49.59%15.62M
-73.04%5.45M
70.90%6.4M
Cost of revenue
Gross profit
Operating expense
-26.12%15.14M
-24.89%15.64M
-2.25%84.58M
9.74%22.57M
-14.79%20.69M
-3.93%20.49M
2.37%20.83M
32.86%86.52M
18.01%20.56M
32.90%24.28M
Selling and administrative expenses
-0.26%5.31M
13.70%6M
12.27%24.93M
68.39%8.29M
11.16%6.03M
-8.95%5.32M
-12.11%5.28M
23.24%22.2M
-3.18%4.93M
10.93%5.43M
-General and administrative expense
-0.26%5.31M
13.70%6M
12.27%24.93M
68.39%8.29M
11.16%6.03M
-8.95%5.32M
-12.11%5.28M
23.24%22.2M
-3.18%4.93M
10.93%5.43M
Research and development costs
-35.20%9.83M
-37.98%9.65M
-7.26%59.65M
-8.73%14.27M
-22.26%14.65M
-2.04%15.17M
8.43%15.55M
36.54%64.32M
26.75%15.64M
40.93%18.85M
Operating profit
18.12%-15.14M
-0.83%-15.64M
-6.36%-75.42M
-44.95%-21.91M
-9.10%-19.5M
11.75%-18.49M
8.53%-15.52M
-107.70%-70.9M
-641.33%-15.11M
-23.10%-17.88M
Net non-operating interest income expense
Other net income (expense)
7.05%1.47M
-136.65%-475K
231.42%7.09M
121.93%2.26M
301.49%2.16M
198.91%1.38M
2,744.90%1.3M
2.14M
1.02M
538K
Gain on sale of security
39.03%1.92M
63.12%2.11M
230.90%7.11M
123.96%2.27M
293.09%2.16M
200.22%1.38M
--1.3M
--2.15M
--1.01M
--550K
Special income (charges)
---683K
---2.58M
----
----
----
--0
--0
----
----
----
-Less：Restructuring and merger&acquisition
--683K
--2.58M
----
----
----
--0
--0
----
----
----
Other non- operating income (expenses)
4,016.67%235K
---7K
-120.00%-22K
-566.67%-14K
83.33%-2K
---6K
----
---10K
--3K
---12K
Income before tax
20.14%-13.67M
-13.36%-16.12M
0.64%-68.33M
-39.40%-19.65M
-0.03%-17.34M
16.48%-17.12M
15.56%-14.22M
-101.57%-68.77M
-604.00%-14.1M
-19.45%-17.34M
Income tax
62K
27K
-162K
0
0
0
Net income
19.78%-13.73M
-13.55%-16.15M
0.87%-68.17M
-38.25%-19.49M
-0.03%-17.34M
16.48%-17.12M
15.56%-14.22M
-101.57%-68.77M
-604.00%-14.1M
-19.45%-17.34M
Net income continuous Operations
19.78%-13.73M
-13.55%-16.15M
0.87%-68.17M
-38.25%-19.49M
-0.03%-17.34M
16.48%-17.12M
15.56%-14.22M
-101.57%-68.77M
-604.00%-14.1M
-19.45%-17.34M
Minority interest income
Net income attributable to the parent company
19.78%-13.73M
-13.55%-16.15M
0.87%-68.17M
-38.25%-19.49M
-0.03%-17.34M
16.48%-17.12M
15.56%-14.22M
-101.57%-68.77M
-604.00%-14.1M
-19.45%-17.34M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
19.78%-13.73M
-13.55%-16.15M
0.87%-68.17M
-38.25%-19.49M
-0.03%-17.34M
16.48%-17.12M
15.56%-14.22M
-101.57%-68.77M
-604.00%-14.1M
-19.45%-17.34M
Basic earnings per share
36.36%-0.28
15.38%-0.33
14.21%-1.63
-2.56%-0.4
16.67%-0.4
22.81%-0.44
17.02%-0.39
-55.74%-1.9
-262.50%-0.39
-20.00%-0.48
Diluted earnings per share
36.36%-0.28
15.38%-0.33
14.21%-1.63
-2.56%-0.4
16.67%-0.4
22.81%-0.44
17.02%-0.39
-55.74%-1.9
-262.50%-0.39
-20.00%-0.48
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 00-41.35%9.16M-87.91%659K-81.49%1.19M424.61%2M57.00%5.31M-49.59%15.62M-73.04%5.45M70.90%6.4M
Operating revenue --0--0-41.35%9.16M-87.91%659K-81.49%1.19M424.61%2M57.00%5.31M-49.59%15.62M-73.04%5.45M70.90%6.4M
Cost of revenue
Gross profit
Operating expense -26.12%15.14M-24.89%15.64M-2.25%84.58M9.74%22.57M-14.79%20.69M-3.93%20.49M2.37%20.83M32.86%86.52M18.01%20.56M32.90%24.28M
Selling and administrative expenses -0.26%5.31M13.70%6M12.27%24.93M68.39%8.29M11.16%6.03M-8.95%5.32M-12.11%5.28M23.24%22.2M-3.18%4.93M10.93%5.43M
-General and administrative expense -0.26%5.31M13.70%6M12.27%24.93M68.39%8.29M11.16%6.03M-8.95%5.32M-12.11%5.28M23.24%22.2M-3.18%4.93M10.93%5.43M
Research and development costs -35.20%9.83M-37.98%9.65M-7.26%59.65M-8.73%14.27M-22.26%14.65M-2.04%15.17M8.43%15.55M36.54%64.32M26.75%15.64M40.93%18.85M
Operating profit 18.12%-15.14M-0.83%-15.64M-6.36%-75.42M-44.95%-21.91M-9.10%-19.5M11.75%-18.49M8.53%-15.52M-107.70%-70.9M-641.33%-15.11M-23.10%-17.88M
Net non-operating interest income expense
Other net income (expense) 7.05%1.47M-136.65%-475K231.42%7.09M121.93%2.26M301.49%2.16M198.91%1.38M2,744.90%1.3M2.14M1.02M538K
Gain on sale of security 39.03%1.92M63.12%2.11M230.90%7.11M123.96%2.27M293.09%2.16M200.22%1.38M--1.3M--2.15M--1.01M--550K
Special income (charges) ---683K---2.58M--------------0--0------------
-Less：Restructuring and merger&acquisition --683K--2.58M--------------0--0------------
Other non- operating income (expenses) 4,016.67%235K---7K-120.00%-22K-566.67%-14K83.33%-2K---6K-------10K--3K---12K
Income before tax 20.14%-13.67M-13.36%-16.12M0.64%-68.33M-39.40%-19.65M-0.03%-17.34M16.48%-17.12M15.56%-14.22M-101.57%-68.77M-604.00%-14.1M-19.45%-17.34M
Income tax 62K27K-162K000
Net income 19.78%-13.73M-13.55%-16.15M0.87%-68.17M-38.25%-19.49M-0.03%-17.34M16.48%-17.12M15.56%-14.22M-101.57%-68.77M-604.00%-14.1M-19.45%-17.34M
Net income continuous Operations 19.78%-13.73M-13.55%-16.15M0.87%-68.17M-38.25%-19.49M-0.03%-17.34M16.48%-17.12M15.56%-14.22M-101.57%-68.77M-604.00%-14.1M-19.45%-17.34M
Minority interest income
Net income attributable to the parent company 19.78%-13.73M-13.55%-16.15M0.87%-68.17M-38.25%-19.49M-0.03%-17.34M16.48%-17.12M15.56%-14.22M-101.57%-68.77M-604.00%-14.1M-19.45%-17.34M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 19.78%-13.73M-13.55%-16.15M0.87%-68.17M-38.25%-19.49M-0.03%-17.34M16.48%-17.12M15.56%-14.22M-101.57%-68.77M-604.00%-14.1M-19.45%-17.34M
Basic earnings per share 36.36%-0.2815.38%-0.3314.21%-1.63-2.56%-0.416.67%-0.422.81%-0.4417.02%-0.39-55.74%-1.9-262.50%-0.39-20.00%-0.48
Diluted earnings per share 36.36%-0.2815.38%-0.3314.21%-1.63-2.56%-0.416.67%-0.422.81%-0.4417.02%-0.39-55.74%-1.9-262.50%-0.39-20.00%-0.48
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data